Latest Press Releases & News
SAN CARLOS, CALIFORNIA, US, October 11, 2021 /EINPresswire.com/ Alessa Therapeutics, Inc., a clinical-stage drug development company developing implantable drug delivery systems focused on sustained delivery of drugs to solid organ tumors, announced that it has entered into a research collaboration agreement with an affiliate of Janssen Research & Development, LLC. This agreement was facilitated by Johnson […]
SAN CARLOS, CALIFORNIA, US, June 7, 2021 /EINPresswire.com/ Alessa Therapeutics, Inc., a clinical-stage drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug application (IND) for Biolen®. Alessa, in collaboration with […]
SAN CARLOS, CALIFORNIA, US, March 17, 2020 /EINPresswire.com/ Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, announced the enrollment of the first patient in the company’s Biolen-PC clinical study in Australia. Biolen-PC (NCT 04284761) is a first-in-man study […]
The American Diabetes Association’s Leaders Forum HealthTech Showcase hosts over 400 Bay Area biotech, venture capital and investment banking executives. Alessa Therapeutics is proud to be a 2020 finalist in the HealthTech Showcase, which features start-up ventures in the life science and digital health arenas.
New Zealand’s lack of COVID-19 cases saw a world-first prostate cancer surgery taking place in Tauranga. Jim Boltman, 64, says his whole life is “back to normal” after undergoing the new surgery at Tauranga Hospital on October 8. The 64-year-old was diagnosed with prostate cancer after realising he had a problem when he was constantly […]
SAN CARLOS, CALIFORNIA, US, October 13, 2020 /EINPresswire.com/ Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, announced the enrollment of the first patient in the company’s Biolen-PC clinical study. Biolen-PC is a first-in-man study evaluating safety and patient […]